S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
NFLX   349.60 (+7.24%)
BAC   34.12 (-0.70%)
DIS   142.20 (-1.26%)
GILD   63.94 (+0.80%)
Log in
(Ad)
Paul Mampilly correctly predicted every bull and bear market over the last two decades. He made millions. His new "Dow 100,000" prediction is his boldest yet. Even more stunning... Paul reveals how you could make millions as it unfolds.

NASDAQ:OGI - OrganiGram Stock Price, Forecast & News

$2.89
-0.03 (-1.03 %)
(As of 01/23/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.83
Now: $2.89▼
$2.98
50-Day Range
$2.02
MA: $2.52▼
$3.39
52-Week Range
$1.89
Now: $2.89▼
$8.44
Volume4.13 million shs
Average Volume6.21 million shs
Market Capitalization$472.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.organigram.ca/
Phone1-855-961-9420

Debt

Debt-to-Equity Ratio0.24
Current Ratio3.92
Quick Ratio1.36

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio289.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$61.27 million
Price / Sales7.71
Cash Flow$0.10 per share
Price / Cash Flow29.62
Book Value$1.52 per share
Price / Book1.90

Profitability

EPS (Most Recent Fiscal Year)$0.06
Net Income$-7,200,000.00
Net Margins-42.78%
Return on Equity-6.13%
Return on Assets-4.57%

Miscellaneous

Employees615
Outstanding Shares163,382,000
Market Cap$472.17 million
Next Earnings Date4/20/2020 (Estimated)
OptionableNot Optionable

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:OGI Rates by TradingView

(Ad)

Did you know that you could generate up to $1,529.70 in passive income per month without risking your retirement? A virtually unheard-of investment plan is finally letting everyday Americans invest in cannabis without betting the house. The best part? This plan has been around for over 50 years!

OrganiGram (NASDAQ:OGI) Frequently Asked Questions

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) posted its earnings results on Tuesday, November, 26th. The company reported ($0.05) earnings per share (EPS) for the quarter. The business had revenue of $12.29 million for the quarter, compared to analyst estimates of $12.20 million. OrganiGram had a negative return on equity of 6.13% and a negative net margin of 42.78%. View OrganiGram's Earnings History.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release their next quarterly earnings announcement on Monday, April 20th 2020. View Earnings Estimates for OrganiGram.

What price target have analysts set for OGI?

10 brokers have issued 12 month price objectives for OrganiGram's shares. Their forecasts range from $8.20 to $17.10. On average, they anticipate OrganiGram's share price to reach $10.96 in the next twelve months. This suggests a possible upside of 279.2% from the stock's current price. View Analyst Price Targets for OrganiGram.

What is the consensus analysts' recommendation for OrganiGram?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 1 sell rating, 4 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for OrganiGram.

Has OrganiGram been receiving favorable news coverage?

Press coverage about OGI stock has trended extremely positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. OrganiGram earned a news impact score of 4.4 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for OrganiGram.

Are investors shorting OrganiGram?

OrganiGram saw a decrease in short interest in the month of December. As of December 13th, there was short interest totalling 9,340,000 shares, a decrease of 8.4% from the November 28th total of 10,200,000 shares. Based on an average trading volume of 2,620,000 shares, the short-interest ratio is presently 3.6 days. Currently, 6.3% of the shares of the stock are short sold. View OrganiGram's Current Options Chain.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Aphria (APHA), KushCo (KSHB), Charlotte's Web (CWBHF), Innovative Industrial Properties (IIPR), HEXO (HEXO), Alibaba Group (BABA) and NVIDIA (NVDA).

Who are OrganiGram's key executives?

OrganiGram's management team includes the folowing people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a variety of of institutional and retail investors. Top institutional investors include AdvisorShares Investments LLC (0.49%), Wedbush Securities Inc. (0.01%), Rothschild Investment Corp IL (0.01%), AE Wealth Management LLC (0.01%) and Ingalls & Snyder LLC (0.01%).

Which institutional investors are selling OrganiGram stock?

OGI stock was sold by a variety of institutional investors in the last quarter, including Rothschild Investment Corp IL and Ingalls & Snyder LLC.

Which institutional investors are buying OrganiGram stock?

OGI stock was acquired by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, AE Wealth Management LLC and Wedbush Securities Inc..

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $2.89.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $472.17 million and generates $61.27 million in revenue each year. The company earns $-7,200,000.00 in net income (profit) each year or $0.06 on an earnings per share basis. OrganiGram employs 615 workers across the globe.View Additional Information About OrganiGram.

What is OrganiGram's official website?

The official website for OrganiGram is http://www.organigram.ca/.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The company can be reached via phone at 1-855-961-9420.


MarketBeat Community Rating for OrganiGram (NASDAQ OGI)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  212
MarketBeat's community ratings are surveys of what our community members think about OrganiGram and other stocks. Vote "Outperform" if you believe OGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: How interest rates affect municipal bond prices
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel